Skip to content

Vericel VCEL Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Enovis logo
EnovisENOV

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's common stock, shares, outstanding?
Vericel (VCEL) reported common stock, shares, outstanding of $51.01M in Q1 2026.
How has Vericel's common stock, shares, outstanding changed year-over-year?
Vericel's common stock, shares, outstanding increased by 1.5% year-over-year, from $50.25M to $51.01M.
What is the long-term trend for Vericel's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Vericel's common stock, shares, outstanding has grown at a 2.0% compound annual growth rate (CAGR), from $45.8M to $50.62M.